• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

湿磨法制备依托度酸纳米混悬剂的处方和工艺参数研究。

Investigation of Formulation and Process Parameters of Wet Media Milling to Develop Etodolac Nanosuspensions.

机构信息

Faculty of Pharmacy, Department of Pharmaceutical Technology, Gazi University, Etiler-Yenimahalle, Ankara, Turkey.

出版信息

Pharm Res. 2020 May 31;37(6):111. doi: 10.1007/s11095-020-02815-x.

DOI:10.1007/s11095-020-02815-x
PMID:32476048
Abstract

PURPOSE

Etodolac (ETD) is one of the non-steroidal anti-inflammatory drugs which has low aqueous solubility issues. The objective of this study was to develop ETD nanosuspensions to improve its poor aqueous solubility properties while investigating formulation and process parameters of wet media milling method via design of experiment (DoE) approach.

METHODS

The critical formulation parameters (CFP) were selected as ETD amount, stabilizer type and ratio as well as critical process parameters (CPP) which were bead size, milling time and milling speed. The two-factorial-2 and The Box-Benkhen Designs were generated to evaluate CFP and CPP, respectively. Particle size (PS), polydispersity index (PDI) and zeta potential (ZP) were analyzed as dependent variables. Characterization, physical stability and solubility studies were performed.

RESULTS

Optimum nanosuspensions stabilized by PVP K30 and Poloxamer 188 showed 188.5 ± 1.6 and 279.3 ± 6.1 nm of PS, 0.161 ± 0.049 and 0.345 ± 0.007 PDI, 14.8 ± 0.3 and 16.5 ± 0.4 mV of ZP values, respectively. The thermal properties of ETD did not change after milling and lyophilization process regarding to DSC analysis. Also, the crystalline state of ETD was preserved. The morphology of particle was smooth and spherical on SEM. The dry-nanosuspensions stayed physically stable for six months at room temperature. The solubility of nanosuspensions increased up to 13.0-fold in comparison with micronized ETD.

CONCLUSIONS

In conclusion, it is found that the poor solubility issue of ETD can be solved by nanosuspension. DoE approach provided benefits such as reducing number of experiments, saving time and improving final product quality by using wet media milling.

摘要

目的

依托度酸(ETD)是一种非甾体抗炎药,其水溶性问题较低。本研究的目的是制备 ETD 纳米混悬剂以改善其较差的水溶性性质,同时通过实验设计(DoE)方法研究制剂和工艺参数。

方法

选择关键制剂参数(CFP)为 ETD 用量、稳定剂类型和比例以及关键工艺参数(CPP)为珠粒大小、研磨时间和研磨速度。采用两因素两水平和 Box-Benkhen 设计分别评估 CFP 和 CPP。以粒径(PS)、多分散指数(PDI)和 Zeta 电位(ZP)为因变量进行分析。进行了表征、物理稳定性和溶解度研究。

结果

由 PVP K30 和 Poloxamer 188 稳定的最佳纳米混悬剂的 PS 分别为 188.5±1.6 和 279.3±6.1nm,PDI 分别为 0.161±0.049 和 0.345±0.007,ZP 值分别为 14.8±0.3 和 16.5±0.4mV。DSC 分析表明,研磨和冻干过程后 ETD 的热性能没有变化。此外,ETD 的结晶状态得以保留。SEM 显示粒子形态光滑、呈球形。干纳米混悬剂在室温下放置六个月仍保持物理稳定。与微米化 ETD 相比,纳米混悬剂的溶解度增加了 13.0 倍。

结论

总之,研究发现纳米混悬剂可解决 ETD 的溶解度问题。DoE 方法通过湿磨法提供了许多益处,例如减少实验次数、节省时间和提高最终产品质量。

相似文献

1
Investigation of Formulation and Process Parameters of Wet Media Milling to Develop Etodolac Nanosuspensions.湿磨法制备依托度酸纳米混悬剂的处方和工艺参数研究。
Pharm Res. 2020 May 31;37(6):111. doi: 10.1007/s11095-020-02815-x.
2
Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.经皮应用氟比洛芬纳米混悬剂:通过实验设计方法进行优化和体外评价。
Eur J Pharm Sci. 2018 Sep 15;122:254-263. doi: 10.1016/j.ejps.2018.07.009. Epub 2018 Jul 4.
3
A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.基于质量源于设计的硝苯地平纳米混悬剂的研制:考察制剂变量、湿磨工艺参数和辅料变异性对药物产品质量属性的相对影响。
Drug Dev Ind Pharm. 2018 Dec;44(12):1942-1952. doi: 10.1080/03639045.2018.1503296. Epub 2018 Oct 12.
4
The effect of critical process parameters of the high pressure homogenization technique on the critical quality attributes of flurbiprofen nanosuspensions.高压匀质技术的关键工艺参数对氟比洛芬纳米混悬剂关键质量属性的影响。
Pharm Dev Technol. 2019 Dec;24(10):1278-1286. doi: 10.1080/10837450.2019.1667384.
5
Review of nanosuspension formulation and process analysis in wet media milling using microhydrodynamic model and emerging characterization methods.湿磨法中利用微流体动力学模型和新兴表征方法对纳米混悬剂制剂及工艺分析的综述。
Int J Pharm. 2022 Jul 25;623:121862. doi: 10.1016/j.ijpharm.2022.121862. Epub 2022 Jun 4.
6
Etodolac nanosuspension based gel for enhanced dermal delivery: and evaluation.依托度酸纳米混悬剂凝胶剂用于增强经皮给药:制备与评价。
J Microencapsul. 2021 Jun;38(4):218-232. doi: 10.1080/02652048.2021.1895344. Epub 2021 Mar 23.
7
Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach.使用聚合物稳定剂通过微流化法制备利托那韦纳米混悬液:I. 实验设计方法
Eur J Pharm Sci. 2016 Dec 1;95:111-121. doi: 10.1016/j.ejps.2016.05.010. Epub 2016 May 13.
8
Particle Size Tailoring of Quercetin Nanosuspensions by Wet Media Milling Technique: A Study on Processing and Formulation Parameters.采用湿介质研磨技术对槲皮素纳米混悬液进行粒度调整:加工与制剂参数研究
Iran J Pharm Res. 2023 Feb 1;21(1):e130626. doi: 10.5812/ijpr-130626. eCollection 2022 Dec.
9
Preparation of amorphous indomethacin nanoparticles by aqueous wet bead milling and in situ measurement of their increased saturation solubility.通过水相湿磨法制备无定形吲哚美辛纳米粒及其饱和溶解度增加的原位测量。
Eur J Pharm Biopharm. 2018 Apr;125:159-168. doi: 10.1016/j.ejpb.2018.01.013. Epub 2018 Jan 31.
10
Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect.通过湿搅拌介质研磨连续生产药物纳米颗粒悬浮液:重新审视雷宾德效应。
Drug Dev Ind Pharm. 2013 Feb;39(2):266-83. doi: 10.3109/03639045.2012.676048. Epub 2012 Apr 16.

引用本文的文献

1
Characterisation and Stabilisation Mechanisms of Azelaic Acid Nanosuspensions: Insights from a Dual Stabiliser System.壬二酸纳米混悬液的表征及稳定机制:来自双稳定剂系统的见解
Pharmaceutics. 2025 Mar 29;17(4):439. doi: 10.3390/pharmaceutics17040439.
2
Development of Dermal Lidocaine Nanosuspension Formulation by the Wet Milling Method Using Experimental Design: In Vitro/In Vivo Evaluation.采用实验设计通过湿磨法开发皮肤用利多卡因纳米混悬液制剂:体外/体内评价
ACS Omega. 2024 Dec 18;9(52):50992-51008. doi: 10.1021/acsomega.4c05296. eCollection 2024 Dec 31.
3
Development of a Semi-Mechanistic Modeling Framework for Wet Bead Milling of Pharmaceutical Nanosuspensions.
用于药物纳米混悬液湿珠磨的半机理建模框架的开发
Pharmaceutics. 2024 Mar 13;16(3):394. doi: 10.3390/pharmaceutics16030394.
4
Nanosuspension-Based Drug Delivery Systems for Topical Applications.基于纳米混悬剂的经皮给药系统。
Int J Nanomedicine. 2024 Jan 25;19:825-844. doi: 10.2147/IJN.S447429. eCollection 2024.
5
Cotton-Like Three-Dimensional SbOCl Structures: Synthesis and Ammonium Hydroxide Sensing.棉状三维SbOCl结构:合成及氢氧化铵传感
ACS Omega. 2023 Oct 23;8(44):41295-41301. doi: 10.1021/acsomega.3c04751. eCollection 2023 Nov 7.
6
Nanoemulsions as a Promising Carrier for Topical Delivery of Etodolac: Formulation Development and Characterization.纳米乳剂作为依托度酸局部给药的有前景载体:制剂开发与表征
Pharmaceutics. 2023 Oct 23;15(10):2510. doi: 10.3390/pharmaceutics15102510.
7
Formulation Strategies of Nanosuspensions for Various Administration Routes.用于不同给药途径的纳米混悬液的制剂策略
Pharmaceutics. 2023 May 17;15(5):1520. doi: 10.3390/pharmaceutics15051520.
8
Optimization of Naringenin Nanoparticles to Improve the Antitussive Effects on Post-Infectious Cough.优化柚皮苷纳米粒子以提高其对感染后咳嗽的镇咳作用。
Molecules. 2022 Jun 10;27(12):3736. doi: 10.3390/molecules27123736.
9
Increase in Dissolution Rate of Zotepine via Nanomilling Process - Impact of Dried Nanocrystalline Suspensions on Bioavailability.纳米研磨工艺提高佐替平溶出度 - 干燥纳米晶混悬剂对生物利用度的影响。
AAPS PharmSciTech. 2021 Dec 14;23(1):20. doi: 10.1208/s12249-021-02172-x.
10
Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals.盐酸齐拉西酮一水合物纳米晶体的Caco-2细胞渗透性研究
Turk J Pharm Sci. 2021 Apr 20;18(2):223-227. doi: 10.4274/tjps.galenos.2020.67366.